» Articles » PMID: 35926508

The Transcription Factor FoxP3 Can Fold into Two Dimerization States with Divergent Implications for Regulatory T cell Function and Immune Homeostasis

Overview
Journal Immunity
Publisher Cell Press
Date 2022 Aug 4
PMID 35926508
Authors
Affiliations
Soon will be listed here.
Abstract

FoxP3 is an essential transcription factor (TF) for immunologic homeostasis, but how it utilizes the common forkhead DNA-binding domain (DBD) to perform its unique function remains poorly understood. We here demonstrated that unlike other known forkhead TFs, FoxP3 formed a head-to-head dimer using a unique linker (Runx1-binding region [RBR]) preceding the forkhead domain. Head-to-head dimerization conferred distinct DNA-binding specificity and created a docking site for the cofactor Runx1. RBR was also important for proper folding of the forkhead domain, as truncation of RBR induced domain-swap dimerization of forkhead, which was previously considered the physiological form of FoxP3. Rather, swap-dimerization impaired FoxP3 function, as demonstrated with the disease-causing mutation R337Q, whereas a swap-suppressive mutation largely rescued R337Q-mediated functional impairment. Altogether, our findings suggest that FoxP3 can fold into two distinct dimerization states: head-to-head dimerization representing functional specialization of an ancient DBD and swap dimerization associated with impaired functions.

Citing Articles

Elusive modes of Foxp3 activity in versatile regulatory T cells.

He M, Feng Y Front Immunol. 2025; 15:1533823.

PMID: 39882241 PMC: 11774722. DOI: 10.3389/fimmu.2024.1533823.


Footprint-C reveals transcription factor modes in local clusters and long-range chromatin interactions.

Liu X, Wei H, Zhang Q, Zhang N, Wu Q, Xu C Nat Commun. 2024; 15(1):10922.

PMID: 39738122 PMC: 11686180. DOI: 10.1038/s41467-024-55403-7.


Dynamic Foxp3-chromatin interaction controls tunable Treg cell function.

He M, Zong X, Xu B, Qi W, Huang W, Djekidel M J Exp Med. 2024; 221(9).

PMID: 38935023 PMC: 11211070. DOI: 10.1084/jem.20232068.


Deubiquitinating enzymes: potential regulators of the tumor microenvironment and implications for immune evasion.

Hsu S, Chou C, Lin I, Chang W, Kuo I, Chiu C Cell Commun Signal. 2024; 22(1):259.

PMID: 38715050 PMC: 11075295. DOI: 10.1186/s12964-024-01633-7.


DNA controls the dimerization of the human FoxP1 forkhead domain.

Kolimi N, Ballard J, Peulen T, Goutam R, Duffy 3rd F, Ramirez-Sarmiento C Cell Rep Phys Sci. 2024; 5(3).

PMID: 38585429 PMC: 10997372. DOI: 10.1016/j.xcrp.2024.101854.


References
1.
Drouin J . Minireview: pioneer transcription factors in cell fate specification. Mol Endocrinol. 2014; 28(7):989-98. PMC: 5414827. DOI: 10.1210/me.2014-1084. View

2.
Wildin R, Ramsdell F, Peake J, Faravelli F, Casanova J, Buist N . X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet. 2001; 27(1):18-20. DOI: 10.1038/83707. View

3.
Hannenhalli S, Kaestner K . The evolution of Fox genes and their role in development and disease. Nat Rev Genet. 2009; 10(4):233-40. PMC: 2733165. DOI: 10.1038/nrg2523. View

4.
Koh K, Sundrud M, Rao A . Domain requirements and sequence specificity of DNA binding for the forkhead transcription factor FOXP3. PLoS One. 2009; 4(12):e8109. PMC: 2779587. DOI: 10.1371/journal.pone.0008109. View

5.
Jolma A, Yin Y, Nitta K, Dave K, Popov A, Taipale M . DNA-dependent formation of transcription factor pairs alters their binding specificity. Nature. 2015; 527(7578):384-8. DOI: 10.1038/nature15518. View